What is LOPJLB’s current signal on SANA?

LOPJLB’s latest quantitative signal on Sana Biotechnology, Inc. (SANA) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is SANA in?

Sana Biotechnology, Inc. (SANA) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Sana Biotechnology, Inc. based / listed?

Sana Biotechnology, Inc. is based in US, listed on NASDAQ.

Sana Biotechnology, Inc. (SANA)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.79+0.00%Close

SELLCRISIS · day 24

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $776M
Beta: 2.13
P/E (TTM): -3.62

Short % float: 22.29%
Days to cover: 9.0
SI change: -6.4%

1W: -3.46%
1M: -9.71%

vs SPY 1W: -4.62%
vs SPY 1M: -12.70%

Industry peers

FMP comparable companies · ranked by market cap

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Sana Biotechnology, Inc. is a biotechnology firm focused on creating treatments using engineered cells. The company develops advanced ex vivo and in vivo cell engineering platforms to address a range of conditions with significant unmet medical needs, including various cancers,…

Employees: 142
Headquarters: US
Founded: 2021
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Shares out: 278.3M
Float: 62.4%

sana.com ↗

Key executives

Steven D. Harr — President, Chief Executive Officer & Director

Brian D. Piper — Executive Vice President & Chief Financial Officer

Dhavalkumar D. Patel — Executive Vice President & Chief Scientific Officer

SEC filings

EDGAR · CIK 17701210 · SANA

Analyst consensus

Buy

Bullish981.8%

Neutral218.2%

Bearish00.0%

L $7.00Avg $7.00H $7.00

Target$7.00+150.90%

Last$2.79

Key stats

Industry peers

Prediction markets

Company news